Clinical Trial Update: Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment [NA]

View source ↗

Summary

An ongoing clinical trial is exploring markers of primary or acquired resistance to anticancer therapies in melanoma and lung cancers; current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Melanoma, Non Small Cell Lung Cancer | NA | Status: UNKNOWN